Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA (2021) Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol 19(1):135. https://doi.org/10.1186/s12969-021-00629-8

Article  Google Scholar 

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001. J Rheumatol 31(2):390–392

PubMed  Google Scholar 

Okamoto N, Yokota S, Takei S, OkuraY KT, Shimizu M et al (2018) Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018. Mod Rheumatol 29(1):41–59. https://doi.org/10.1080/14397595.2018.1514724

Article  PubMed  Google Scholar 

Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63:465–482. https://doi.org/10.1002/acr.20460

Article  PubMed  Google Scholar 

Vanoni F, Minoia F, Malattia C (2017) Biologics in juvenile idiopathic arthritis: a narrative review. Eur J Pediatr 176(9):1147–1153. https://doi.org/10.1007/s00431-017-2960-6

Article  CAS  PubMed  Google Scholar 

Ruperto N, Lovell DJ, Cuttica R, Woo P, Meiorin S, Wouters C et al (2010) Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis 69(4):718–722. https://doi.org/10.1136/ard.2009.100354

Article  CAS  PubMed  Google Scholar 

Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angelas-Han ST et al (2022) 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Rheumatol 74(4):553–569. https://doi.org/10.1002/art.42037

Article  PubMed  PubMed Central  Google Scholar 

Consolaro A, Giancane G, Schiappapietra B, Davi S, Calandra S, Lanni S et al (2016) Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J 14(1):23. https://doi.org/10.1186/s12969-016-0085-5

Article  PubMed  PubMed Central  Google Scholar 

Demirkaya E, Ozen S, Bilginer Y, Aktay Ayaz N, Bora Makay B, Ünsal E et al (2011) The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 29(1):111–116

PubMed  Google Scholar 

Shen CC, Yeh KW, Ou LS, Yao TC, Chen LC, Huang JL (2013) Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. J Microbiol Immunol Infect 46(4):288–294. https://doi.org/10.1016/j.jmii.2012.03.006

Article  PubMed  Google Scholar 

Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D et al (2009) Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 68(4):519–525. https://doi.org/10.1136/ard.2007.087593

Article  CAS  PubMed  Google Scholar 

Klein-Wieringa IR, Brinkman DMC, Cate R, Hissink Muller PCE (2020) Uptodate on the treatment of nonsystemic juvenile idiopathic arthritis including treatment to target: is (drug-free) inactive disease already possible? Curr Opin Rheumatol 32(5):403–413. https://doi.org/10.1097/BOR.0000000000000727

Article  CAS  PubMed  Google Scholar 

Özdel S, Bağlan E, Kargın Çakıcı E, Yazılıtaş F, Yücel H, Senel S et al (2021) Clinical features in 305 patients with juvenile idiopathic arthritis: a single center Turkish study. Pediatr Int 63(6):636–642. https://doi.org/10.1111/ped.14481

Article  PubMed  Google Scholar 

Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, Ten Cate R et al (2015) Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national arthritis and biologics in children register. Ann Rheum Dis 74(7):1379–1386. https://doi.org/10.1136/annrheumdis-2013-204641

Article  PubMed  Google Scholar 

Davies R, Carrasco R, Foster HE, Baildam EM, Chieng SEA, Davidson JE et al (2016) Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): analysis from the UK Childhood Arthritis Prospective Study (CAPS). Semin Arthritis Rheum 46(2):190–195. https://doi.org/10.1016/j.semarthrit.2016.06.001

Article  PubMed  PubMed Central  Google Scholar 

Batu ED, Sönmez HE, Gülhan BG, Arıcı ZS, Topaloğlu R, Bilginer Y (2017) Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis. Turk J Pediatr 59(1):6–12. https://doi.org/10.24953/turkjped.2017.01.002

Article  PubMed  Google Scholar 

Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC (2021) Oligoarticular juvenile idiopathic arthritis. Textbook of Pediatric Rheumatology, 8th edn. Philedephia, pp 241–250

Google Scholar 

Al-Matar MJ, Petty RE, Tucker LB, Malleson PN, Schroeder ML, Cabral DA (2002) The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheumatol 46(10):2708–2715. https://doi.org/10.1002/art.10544

Article  Google Scholar 

Padeh S, Pinhas-Hamiel O, Zimmermann-Sloutskis D, Berkun Y (2011) Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation. J Pediatr 159(5):832–837. https://doi.org/10.1016/j.jpeds.2011.04.012

Article  PubMed  Google Scholar 

Pelegrin L, Casaroli-Marano R, Anton J, Vicuna MCG, Molina-Prat N, Aro´stegui JI, et al (2014) Predictive value of selected biomarkers, polymorphisms, and clinical features for oligoarticular juvenile idiopathic arthritis-associated uveitis. Ocul Immunol Inflamm 22(3):208–212. https://doi.org/10.3109/09273948.2013.841495

Article  CAS  PubMed  Google Scholar 

Guıllaume S, Prıeur AM, Coste J, Job-Deslandre C (2000) Long-Term Outcome and Prognosıs in Olıgoartıcular-onset Juvenıle Idıopathıc Arthrıtıs. Arthrıtıs Rheumatısm 43:1858–1865

Article  PubMed  Google Scholar 

Swart JF, van Dijkhuizen EHP, Wulffraat NM, Roock S (2018) Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis 77(3):336–342. https://doi.org/10.1136/annrheumdis-2017-212104

Article  CAS  PubMed  Google Scholar